Welltend Technology Corporation (3021) Fair Value & Analysis
Technology · TW · Market cap 2.8B TWD
Fair value as of: Jun 24, 2026
Analysis
Welltend Technology Corporation (3021) currently trades at 28.95 TWD, while our model-based Fair Value estimate is 16.99 TWD — implying the stock looks roughly 41.3% overvalued today. We read business quality at 92/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Welltend Technology Corporation sells wires and connectors in Taiwan, Mainland China, the Philippines, and Thailand. The company operates through Information Service Department and Wire & Connectors Department segments. It offers system integration services, which include information infrastructure, custom software development, and professional IT consulting. The company provides server virtualization, data loss prevention, database upgrade, geography intelligent system, on-site engineers and maintenance service, and web-based workflow services. In addition, it produces and sells computer peripherals, smart home appliances, communication equipment, and game consoles, as well as engages in the investment, international trade, other wholesale, and retail trade businesses. Welltend Technology Corporation was founded in 1973 and is based in Taipei, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Welltend Technology Corporation (3021) undervalued?
What is the fair value of 3021?
What is the quality score of 3021?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.